Nuacht

Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.
The defect has resulted in problems including a procedural delay, difficulty removing device fragments and bleeding, the FDA said.
The orthopedics firm is looking to round out its robotics offerings with the planned $177 million acquisition. Some analysts ...
The demonstration of a trans-Atlantic operation using Intuitive Surgical’s da Vinci 5 robot on a tissue model was a focus at ...
The money will also help the company complete enrollment in a randomized controlled trial of patients with newly diagnosed ...
Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...
J&J’s electrophysiology group returned to growth in the second quarter after a decline in the prior quarter. Now, can the ...
The deal allows Zimmer to sell Getinge’s infection control and surgical products alongside its orthopedic implants and robots ...
The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...
Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small ...
The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading Monday on the news.
Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...